The analysis also identified potentially novel enhancer-hijacking oncogenes such as CRKL and ID4. We have made the HAPI analysis tool publicly available (10.24433/CO.1110712.v1) and anticipate its broader application in cancer driver discovery and mechanism investigation. The gene discussed is CRKL; the disease is cancer.